Delayed intranasal delivery of hypoxic-preconditioned bone marrow mesenchymal stem cells enhanced cell homing and therapeutic benefits after ischemic stroke in mice

Cell Transplantation

Volumn 22, Issue 6, 2013, Pages 977-991

  Wei, Ning ^a,b   Yu, Shan Ping ^a   Gu, Xiaohuan ^a   Taylor, Tammi M ^a   Song, Denise ^a   Liu, Xin Feng ^b   Wei, Ling ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Bone marrow mesenchymal stem cells (BMSCs); Cell homing; Hypoxic preconditioning; Intranasal delivery; Ischemic stroke

Indexed keywords

CELL SURFACE MARKER; CHEMOKINE RECEPTOR CXCR4; GELATINASE A; GELATINASE B;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW MESENCHYMAL STEM CELL TRANSPLANTATION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN REGION; CELL HOMING; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; FEASIBILITY STUDY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IN VITRO STUDY; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

ADMINISTRATION, INTRANASAL; ANIMALS; BONE MARROW CELLS; BRAIN INFARCTION; BRAIN ISCHEMIA; CELL DEATH; CELL HYPOXIA; CELL MOVEMENT; CELL SEPARATION; CELL SURVIVAL; ISCHEMIC PRECONDITIONING; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; RATS; RATS, WISTAR; RECEPTORS, CXCR4; RECOVERY OF FUNCTION; STROKE;

EID: 84877709953     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368912X657251     Document Type: Article

References (59)

1. Ankrum, J.; Karp, J. M. Mesenchymal stem cell therapy: Two steps forward, one step back. Trends Mol. Med. 16(5):203-209; 2010.
2. Baker, A. H.; Sica, V.; Work, L. M.; Williams-Ignarro, S.; de Nigris, F.; Lerman, L. O.; Casamassimi, A.; Lanza, A.; Schiano, C.; Rienzo, M.; Ignarro, L. J.; Napoli, C. Brain protection using autologous bone marrow cell, metalloproteinase inhibitors, and metabolic treatment in cerebral ischemia. Proc. Natl. Acad. Sci. USA 104(9):3597-3602; 2007.
3. Bang, O. Y.; Lee, J. S.; Lee, P. H.; Lee, G. Autologous mesenchymal stem cell transplantation in stroke patients. Ann. Neurol. 57(6):874-882; 2005.
4. Barbash, I. M.; Chouraqui, P.; Baron, J.; Feinberg, M. S.; Etzion, S.; Tessone, A.; Miller, L.; Guetta, E.; Zipori, D.; Kedes, L. H.; Kloner, R. A.; Leor, J. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: Feasibility, cell migration, and body distribution. Circulation 108(7):863-868; 2003.
5. Bergeron, M.; Gidday, J. M.; Yu, A. Y.; Semenza, G. L.; Ferriero, D. M.; Sharp, F. R. Role of hypoxia-inducible factor-1 in hypoxia-induced ischemic tolerance in neonatal rat brain. Ann. Neurol. 48(3):285-296; 2000.
6. Bouet, V.; Boulouard, M.; Toutain, J.; Divoux, D.; Bernaudin, M.; Schumann-Bard, P.; Freret, T. The adhesive removal test: A sensitive method to assess sensorimotor deficits in mice. Nat. Protoc. 4(10):1560-1564; 2009.
7. Brenneman, M.; Sharma, S.; Harting, M.; Strong, R.; Cox, Jr., C. S.; Aronowski, J.; Grotta, J. C.; Savitz, S. I. Autologous bone marrow mononuclear cells enhance recovery after acute ischemic stroke in young and middleaged rats. J. Cereb. Blood Flow Metab. 30(1):140-149; 2010.
8. Chen, J.; Li, Y.; Wang, L.; Zhang, Z.; Lu, D.; Lu, M.; Chopp, M. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 32(4):1005-1011; 2001.
9. Danielyan, L.; Schafer, R.; von Ameln-Mayerhofer, A.; Bernhard, F.; Verleysdonk, S.; Buadze, M.; Lourhmati, A.; Klopfer, T.; Schaumann, F.; Schmid, B.; Koehle, C.; Proksch, B.; Weissert, R.; Reichardt, H. M.; van den Brandt, J.; Buniatian, G. H.; Schwab, M.; Gleiter, C. H.; Frey, 2nd. W. HTherapeutic efficacy of intranasally delivered mesenchymal stem cells in a rat model of Parkinson disease. Rejuvenation Res. 14(1):3-16; 2011.
10. Danielyan, L.; Schafer, R.; von Ameln-Mayerhofer, A.; Buadze, M.; Geisler, J.; Klopfer, T.; Burkhardt, U.; Proksch, B.; Verleysdonk, S.; Ayturan, M.; Buniatian, G. H.; Gleiter, C. H.; Frey, 2nd. W. H. Intranasal delivery of cells to the brain. I. Eur. J. Cell Biol. 88(6):315-324; 2009.
11. De Becker, A.; Van Hummelen, P.; Bakkus, M.; Vande Broek, I.; De Wever, J.; De Waele, M.; Van Riet, I. Migration of culture-expanded human mesenchymal stem cells through bone marrow endothelium is regulated by matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-3. Haematologica 92(4):440-449; 2007.
12. Dhuria, S. V.; Hanson, L. R.; Frey, 2nd. W. H. Intranasal delivery to the central nervous system: Mechanisms and experimental considerations. J. Pharm. Sci. 99(4):1654- 1673; 2010.
13. Dominici, M.; Le Blanc, K.; Mueller, I.; Slaper-Cortenbach, I.; Marini, F.; Krause, D.; Deans, R.; Keating, A.; Prockop, D.; Horwitz, E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8(4):315-317; 2006.
14. Fischer, U. M.; Harting, M. T.; Jimenez, F.; Monzon-- Posadas, W. O.; Xue, H.; Savitz, S. I.; Laine, G. A.; Cox, Jr., C. S. Pulmonary passage is a major obstacle for intravenous stem cell delivery: The pulmonary first-pass effect. Stem Cells Dev. 18(5):683-692; 2009.
15. Guerra-Crespo, M.; Sistos, A.; Gleason, D.; Fallon, J. H. Intranasal administration of PEGylated transforming growth factor-α improves behavioral deficits in a chronic stroke model. J. Stroke Cerebrovasc. Dis. 19(1):3-9; 2010.
16. Hadaczek, P.; Yamashita, Y.; Mirek, H.; Tamas, L.; Bohn, M. C.; Noble, C.; Park, J. W.; Bankiewicz, K. The perivascular pump driven by arterial pulsation is a powerful mechanism for the distribution of therapeutic molecules within the brain. Mol. Ther. 14(1):69-78; 2006.
17. Harting, M. T.; Jimenez, F.; Xue, H.; Fischer, U. M.; Baumgartner, J.; Dash, P. K.; Cox, C. S. Intravenous mesenchymal stem cell therapy for traumatic brain injury. J. Neurosurg. 110(6):1189-1197; 2009.
18. Hauger, O.; Frost, E. E.; van Heeswijk, R.; Deminiere, C.; Xue, R.; Delmas, Y.; Combe, C.; Moonen, C. T.; Grenier, N.; Bulte, J. W. MR evaluation of the glomerular homing of magnetically labeled mesenchymal stem cells in a rat model of nephropathy. Radiology 238(1):200-210; 2006.
19. Honmou, O.; Houkin, K.; Matsunaga, T.; Niitsu, Y.; Ishiai, S.; Onodera, R.; Waxman, S. G.; Kocsis, J. D. Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke. Brain 134(Pt 6):1790- 1807; 2011.
20. Hu, X.; Wei, L.; Taylor, T. M.; Wei, J.; Zhou, X.; Wang, J. A.; Ping Yu, S. Hypoxic preconditioning enhances bone marrow mesenchymal stem cell migration via Kv2.1 channel and FAK activation. Am. J. Physiol. Cell Physiol. 301(2):C362-C372; 2011.
21. Hu, X.; Yu, S. P.; Fraser, J. L.; Lu, Z.; Ogle, M. E.; Wang, J. A.; Wei L. Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. J. Thorac. Cardiovasc. Surg. 135(4):799-808; 2008.
22. Jasmin; Torres, A. L.; Nunes, H. M.; Passipieri, J. A.; Jelicks, L. A.; Gasparetto, E. L.; Spray, D. C.; Campos de Carvalho, A. C.; Mendez-Otero, R. Optimized labeling of bone marrow mesenchymal cells with superparamagnetic iron oxide nanoparticles and in vivo visualization by magnetic resonance imaging. J. Nanobiotechnology 9(1): 4; 2011.
23. Kamota, T.; Li, T. S.; Morikage, N.; Murakami, M.; Ohshima, M.; Kubo, M.; Kobayashi, T.; Mikamo, A.; Ikeda, Y.; Matsuzaki, M.; Hamano, K. Ischemic preconditioning enhances the mobilization and recruitment of bone marrow stem cells to protect against ischemia/reperfusion injury in the late phase. J. Am. Coll. Cardiol. 53(19):1814-1822; 2009.
24. Karp, J. M.; Leng Teo, G. S. Mesenchymal stem cell homing: The devil is in the details. Cell Stem Cell 4(3):206- 216; 2009.
25. Kim, D.; Chun, B. G.; Kim, Y. K.; Lee, Y. H.; Park, C. S.; Jeon, I.; Cheong, C.; Hwang, T. S.; Chung, H.; Gwag, B. J.; Hong, K. S.; Song, J. In vivo tracking of human mesenchymal stem cells in experimental stroke. Cell Transplant. 16(10):1007-1012; 2007.
26. Kraitchman, D. L.; Tatsumi, M.; Gilson, W. D.; Ishimori, T.; Kedziorek, D.; Walczak, P.; Segars, W. P.; Chen, H. H.; Fritzges, D.; Izbudak, I.; Young, R. G.; Marcelino, M.; Pittenger, M. F.; Solaiyappan, M.; Boston, R. C.; Tsui, B. M.; Wahl, R. L.; Bulte, J. W. Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction. Circulation 112(10):1451-1461; 2005.
27. Lee, J. S.; Hong, J. M.; Moon, G. J.; Lee, P. H.; Ahn, Y. H.; Bang, O. Y. A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke. Stem Cells 28(6):1099- 1106; 2010.
28. Liang, C. C.; Park, A. Y.; Guan, J. L. In vitro scratch assay: A convenient and inexpensive method for analysis of cell migration in vitro. Nat. Protoc. 2(2):329-333; 2007.
29. Lubjuhn, J.; Gastens, A.; von Wilpert, G.; Bargiotas, P.; Herrmann, O.; Murikinati, S.; Rabie, T.; Marti, H. H.; Amende, I.; Hampton, T. G.; Schwaninger, M. Functional testing in a mouse stroke model induced by occlusion of the distal middle cerebral artery. J. Neurosci. Methods 184(1):95-103; 2009.
30. Ma, Y. P.; Ma, M. M.; Cheng, S. M.; Ma, H. H.; Yi, X. M.; Xu, G. L.; Liu, X. F. Intranasal bFGF-induced progenitor cell proliferation and neuroprotection after transient focal cerebral ischemia. Neurosci. Lett. 437(2):93-97; 2008.
31. Meyerrose, T. E.; De Ugarte, D. A.; Hofling, A. A.; Herrbrich, P. E.; Cordonnier, T. D.; Shultz, L. D.; Eagon, J. C.; Wirthlin, L.; Sands, M. S.; Hedrick, M. A.; Nolta, J. A. In vivo distribution of human adipose-derived mesenchymal stem cells in novel xenotransplantation models. Stem Cells 25(1):220-227; 2007.
32. Mezey, E.; Chandross, K. J.; Harta, G.; Maki, R. A.; McKercher, S. R. Turning blood into brain: Cells bearing neuronal antigens generated in vivo from bone marrow. Science 290(5497):1779-1782; 2000.
33. Mezey, E.; Key, S.; Vogelsang, G.; Szalayova, I.; Lange, G. D.; Crain, B. Transplanted bone marrow generates new neurons in human brains. Proc. Natl. Acad. Sci. USA 100(3):1364-1369; 2003.
34. Ohtaki, H.; Ylostalo, J. H.; Foraker, J. E.; Robinson, A. P.; Reger, R. L.; Shioda, S.; Prockop, D. J. Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses. Proc. Natl. Acad. Sci. USA 105(38):14638-14643; 2008.
35. Ries, C.; Egea, V.; Karow, M.; Kolb, H.; Jochum, M.; Neth, P. MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: Differential regulation by inflammatory cytokines. Blood 109(9):4055-4063; 2007.
36. Rosova, I.; Dao, M.; Capoccia, B.; Link, D.; Nolta, J. A. Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem Cells 26(8):2173-2182; 2008.
37. Sackstein, R.; Merzaban, J. S.; Cain, D. W.; Dagia, N. M.; Spencer, J. A.; Lin, C. P.; Wohlgemuth, R. Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone. Nat. Med. 14(2):181-187; 2008.
38. Salem, H. K.; Thiemermann, C. Mesenchymal stromal cells: Current understanding and clinical status. Stem Cells 28(3):585-596; 2010.
39. Sarabi, A. S.; Shen, H.; Wang, Y.; Hoffer, B. J.; Backman, C. M. Gene expression patterns in mouse cortical penumbra after focal ischemic brain injury and reperfusion. J. Neurosci. Res. 86(13):2912-2924; 2008.
40. Savitz, S. I.; Chopp, M.; Deans, R.; Carmichael, S. T.; Phinney, D.; Wechsler, L. Stem cell therapy as an emerging paradigm for stroke (STEPS) II. Stroke 42(3):825- 829; 2011.
41. Shi, M.; Li, J.; Liao, L.; Chen, B.; Li, B.; Chen, L.; Jia, H.; Zhao, R. C. Regulation of CXCR4 expression in human mesenchymal stem cells by cytokine treatment: Role in homing efficiency in NOD/SCID mice. Haematologica 92(7):897-904; 2007.
42. Song, C. H.; Honmou, O.; Furuoka, H.; Horiuchi, M. Identification of chemoattractive factors involved in the migration of bone marrow-derived mesenchymal stem cells to brain lesions caused by prions. J. Virology 85(21): 11069-11078; 2011.
43. Song, C. H.; Honmou, O.; Ohsawa, N.; Nakamura, K.; Hamada, H.; Furuoka, H.; Hasebe, R.; Horiuchi, M. Effect of transplantation of bone marrow-derived mesenchymal stem cells on mice infected with prions. J. Virology 83(11):5918-5927; 2009.
44. Stowe, A. M.; Altay, T.; Freie, A. B.; Gidday, J. M. Repetitive hypoxia extends endogenous neurovascular protection for stroke. Ann. Neurol. 69(6):975-985; 2011.
45. Suarez-Monteagudo, C.; Hernandez-Ramirez, P.; Alvarez-Gonzalez, L.; Garcia-Maeso, I.; de la Cuetara-Bernal, K.; Castillo-Diaz, L.; Bringas-Vega, M. L.; Martinez-Aching, G.; Morales-Chacon, L. M.; Baez-Martin, M. M.; Sanchez-Catasus, C.; Carballo-Barreda, M.; Rodriguez-Rojas, R.; Gomez-Fernandez, L.; Alberti-Amador, E.; Macias-Abraham, C.; Balea, E. D.; Rosales, L. C.; Del Valle Perez, L.; Ferrer, B. B.; Gonzalez, R. M.; Bergado, J. A. Autologous bone marrow stem cell neurotransplantation in stroke patients. An open study. Restor. Neurol. Neurosci. 27(3):151-161; 2009.
46. Swanson, R. A.; Morton, M. T.; Tsao-Wu, G.; Savalos, R. A.; Davidson, C.; Sharp, F. R. A semiautomated method for measuring brain infarct volume. J. Cereb. Blood Flow Metab. 10(2):290-293; 1990.
47. Tang, Y. L.; Zhu, W.; Cheng, M.; Chen, L.; Zhang, J.; Sun, T.; Kishore, R.; Phillips, M. I.; Losordo, D. W.; Qin, G. Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression. Circ. Res. 104(10):1209- 1216; 2009.
48. Theus, M. H.; Wei, L.; Cui, L.; Francis, K.; Hu, X.; Keogh, C.; Yu, S. P. In vitro hypoxic preconditioning of embryonic stem cells as a strategy of promoting cell survival and functional benefits after transplantation into the ischemic rat brain. Exp. Neurol. 210(2):656-670; 2008.
49. Thorne, R. G.; Pronk, G. J.; Padmanabhan, V.; Frey, 2nd. W. H. Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration. Neuroscience 127(2):481-496; 2004.
50. Tran-Dinh, A.; Kubis, N.; Tomita, Y.; Karaszewski, B.; Calando, Y.; Oudina, K.; Petite, H.; Seylaz, J.; Pinard, E. In vivo imaging with cellular resolution of bone marrow cells transplanted into the ischemic brain of a mouse. Neuroimage 31(3):958-967; 2006.
51. van Velthoven, C. T.; Kavelaars, A.; van Bel, F.; Heijnen, C. J. Nasal administration of stem cells: A promising novel route to treat neonatal ischemic brain damage. Pediatr. Res. 68(5):419-422; 2010.
52. Wagner, J.; Kean, T.; Young, R.; Dennis, J. E.; Caplan, A. I. Optimizing mesenchymal stem cell-based therapeutics. Curr. Opin. Biotechnol. 20(5):531-536; 2009.
53. Wakabayashi, K.; Nagai, A.; Sheikh, A. M.; Shiota, Y.; Narantuya, D.; Watanabe, T.; Masuda, J.; Kobayashi, S.; Kim, S. U.; Yamaguchi, S. Transplantation of human mesenchymal stem cells promotes functional improvement and increased expression of neurotrophic factors in a rat focal cerebral ischemia model. J. Neurosci. Res. 88(5):1017-1025; 2010.
54. Walczak, P.; Zhang, J.; Gilad, A. A.; Kedziorek, D. A.; Ruiz-Cabello, J.; Young, R. G.; Pittenger, M. F.; van Zijl, P. C.; Huang, J.; Bulte, J. W. Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia. Stroke 39(5):1569-1574; 2008.
55. Wang, Z. L.; Cheng, S. M.; Ma, M. M.; Ma, Y. P.; Yang, J. P.; Xu, G. L.; Liu, X. F. Intranasally delivered bFGF enhances neurogenesis in adult rats following cerebral ischemia. Neurosci. Lett. 446(1):30-35; 2008.
56. Wei, L.; Keogh, C. L.; Whitaker, V. R.; Theus, M. H.; Yu, S. P. Angiogenesis and stem cell transplantation as potential treatments of cerebral ischemic stroke. Pathophysiology 12(1):47-62; 2005.
57. Whitaker, V. R.; Cui, L.; Miller, S.; Yu, S. P.; Wei, L. Whisker stimulation enhances angiogenesis in the barrel cortex following focal ischemia in mice. J. Cereb. Blood Flow Metab. 27(1):57-68; 2007.
58. Woodbury, D.; Schwarz, E. J.; Prockop, D. J.; Black, I. B. Adult rat and human bone marrow stromal cells differentiate into neurons. J. Neurosci. Res. 61(4):364-370; 2000.
59. Wu, J.; Sun, Z.; Sun, H. S.; Weisel, R. D.; Keating, A.; Li, Z. H.; Feng, Z. P.; Li, R. K. Intravenously administered bone marrow cells migrate to damaged brain tissue and improve neural function in ischemic rats. Cell Transplant. 16(10):993-1005; 2007.